X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10426) 10426
Publication (669) 669
Newsletter (429) 429
Book Chapter (152) 152
Book Review (145) 145
Newspaper Article (97) 97
Magazine Article (32) 32
Book / eBook (20) 20
Transcript (8) 8
Conference Proceeding (7) 7
Trade Publication Article (4) 4
Dissertation (3) 3
Reference (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7947) 7947
atrial fibrillation (6526) 6526
cardiac & cardiovascular systems (5047) 5047
male (5043) 5043
female (4861) 4861
index medicus (4272) 4272
middle aged (4031) 4031
aged (3656) 3656
atrial fibrillation - drug therapy (2324) 2324
treatment outcome (2278) 2278
electrocardiography (2166) 2166
catheter ablation (2053) 2053
adult (1899) 1899
anti-arrhythmia agents - therapeutic use (1813) 1813
atrial fibrillation - physiopathology (1801) 1801
risk factors (1745) 1745
cardiac arrhythmia (1739) 1739
ablation (1591) 1591
atrial fibrillation - therapy (1377) 1377
atrial fibrillation - surgery (1347) 1347
cardiology (1340) 1340
care and treatment (1299) 1299
stroke (1296) 1296
fibrillation (1173) 1173
follow-up studies (1146) 1146
atrial fibrillation - diagnosis (1130) 1130
cardiovascular (1119) 1119
atrial flutter - drug therapy (1085) 1085
aged, 80 and over (1037) 1037
analysis (1026) 1026
management (1012) 1012
recurrence (1003) 1003
atrial flutter (999) 999
heart (994) 994
atrial-fibrillation (982) 982
drug therapy (975) 975
time factors (972) 972
mortality (961) 961
flutter (956) 956
medicine & public health (929) 929
retrospective studies (922) 922
prevention (916) 916
prospective studies (911) 911
risk (901) 901
atrial fibrillation - complications (887) 887
tachycardia (870) 870
catheter ablation - methods (867) 867
arrhythmia (866) 866
sinus rhythm (845) 845
efficacy (828) 828
atrial fibrillation - epidemiology (792) 792
electric countershock (790) 790
anticoagulants (774) 774
heart failure (739) 739
therapy (727) 727
atrial fibrillation - etiology (721) 721
abridged index medicus (712) 712
arrhythmias (707) 707
research (677) 677
surgery (672) 672
amiodarone (654) 654
anti-arrhythmia drugs (648) 648
animals (647) 647
patients (642) 642
anticoagulants - therapeutic use (636) 636
pulmonary vein isolation (633) 633
warfarin (633) 633
prevalence (625) 625
pharmacology & pharmacy (623) 623
medicine, general & internal (622) 622
prognosis (622) 622
radiofrequency ablation (619) 619
cardiac patients (610) 610
follow-up (605) 605
anti-arrhythmia agents - adverse effects (596) 596
cardioversion (590) 590
incidence (565) 565
medical research (561) 561
atrial flutter - physiopathology (550) 550
risk assessment (518) 518
heart conduction system - physiopathology (508) 508
medicine, experimental (506) 506
atrial fibrillation - prevention & control (504) 504
anti-arrhythmia agents - administration & dosage (500) 500
safety (499) 499
health aspects (497) 497
engineering, biomedical (493) 493
radiofrequency catheter ablation (485) 485
pulmonary veins - surgery (476) 476
cardiovascular disease (467) 467
amiodarone - therapeutic use (464) 464
atrial flutter - therapy (463) 463
catheters (463) 463
echocardiography (460) 460
adolescent (459) 459
heart rate - drug effects (456) 456
electrophysiology (453) 453
heart rate (450) 450
arrhythmias, cardiac - drug therapy (449) 449
stroke - prevention & control (438) 438
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10606) 10606
German (227) 227
French (92) 92
Russian (61) 61
Italian (58) 58
Spanish (43) 43
Japanese (17) 17
Polish (12) 12
Chinese (11) 11
Portuguese (10) 10
Czech (6) 6
Danish (5) 5
Hungarian (4) 4
Dutch (3) 3
Lithuanian (3) 3
Korean (2) 2
Norwegian (2) 2
Romanian (2) 2
Turkish (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2011, Volume 27, Issue 1, pp. 74 - 90
Abstract The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to... 
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT-CURRENT CARDIOVERSION | QUALITY-OF-CARE | ORAL ANTICOAGULATION | ACUTE ISCHEMIC-STROKE | ADJUSTED-DOSE WARFARIN | ACUTE MYOCARDIAL-INFARCTION | HEART RHYTHM ASSOCIATION | FIXED MINIDOSE WARFARIN | CLINICAL CLASSIFICATION SCHEMES | Humans | Electric Countershock | Warfarin - adverse effects | Dabigatran | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Platelet Aggregation Inhibitors - therapeutic use | beta-Alanine - analogs & derivatives | Atrial Flutter - etiology | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Evidence-Based Medicine | Randomized Controlled Trials as Topic | Atrial Flutter - complications | Canada | Atrial Fibrillation - etiology | Atrial Flutter - drug therapy | Aged | Hemorrhage - chemically induced
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal Article